We shown that, in distinction to classical opioid receptors, ACKR3 doesn't trigger classical G protein signaling and is not modulated from the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists for instance naloxone. Rather, we proven that LIH383, an ACKR3-selective subnanomolar competitor https://enricov158tql8.life-wiki.com/user